ACICLOVIR AGILA aciclovir (as sodium) 250 mg powder for injection vial

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

aciclovir sodium dihydrate, Quantity: 314.4 mg (Equivalent: aciclovir, Qty 250 mg)

제공처:

Alphapharm Pty Ltd

약제 형태:

Injection, powder for

구성:

Excipient Ingredients:

관리 경로:

Intravenous

패키지 단위:

5 vials

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Aciclovir Agila (aciclovir sodium) is indicated for:,- Promoting resolution of acute clinical manifestations of mucocutaneous Herpes simplex virus infections in immunocompromised patients,- Treatment of severe first episode primary or non-primary genital herpes in immune competent patients,- Treatment of acute manifestations of Varicella zoster virus infection in immunocompromised patients,- Treatment of Herpes zoster (shingles) in immune competent patients who show very severe acute local or systemic manifestations of the disease. (Benefits can be expected in patients with rash duration shorter than 72 hours. The use of the intravenous infusion may be warranted in only a small subgroup of immune competent patients with shingles).,- Treatment of Herpes simplex encephalitis.

제품 요약:

Visual Identification: White to off-white lyophilized powder or cake; Container Type: Vial; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

승인 상태:

Registered

승인 날짜:

2021-05-28